PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm CEO Paul Rennie to transition to Non-Exec Chairman, page-26

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    Paradigm seems to be making all the right moves at a critical stage in its lifecycle, from the addition of Dr Reiter to the team to relegating PR to Chairman where he will oversee the strategic direction for PAR, which is where PR's strengths lay.

    My prediction is they will select a CEO who has experience with NDA submissions and striking licensing and distribution deals. I wouldn't at all be surprised if PAR's next CEO previously worked in an executive position at BioMarin or a similar sized company, but we do need someone who can take PAR to the next level and beyond.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.